InvestorsHub Logo
Followers 62
Posts 7548
Boards Moderated 1
Alias Born 01/02/2003

Re: Whalatane post# 412859

Sunday, 07/23/2023 6:53:39 AM

Sunday, July 23, 2023 6:53:39 AM

Post# of 425795
KIWI...QUOTE..."They can afford to run their generic V as a loss leader ...until AMRN drops out of the US market ."

Generic companies are not doing so well lately. Therefore...

-Generic companies will be hesitant to sell large volumes of gV at a loss to them.
-Vascepa will not drop out of the US market...It will, in any event, be taken over by a BP, which will continue it on a global scale...with new EPA configurations and new EPA products, as previously discussed.

Vascepa is not going away..although Amarin will eventuall be bot by a BP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News